SNY Stock Summary and Trading Ideas (Sanofi - American Depositary Shares | NASDAQ:SNY)

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Sanofi - American Depositary Shares trades on the NASDAQ stock market under the symbol SNY.

As of March 6, 2026, SNY stock price declined to $44.55 with 4,192,565 million shares trading.

SNY has a beta of 0.69, meaning it tends to be less sensitive to market movements. SNY has a correlation of 0.16 to the broad based SPY ETF.

SNY has a market cap of $107.60 billion. This is considered a Large Cap stock.

Last quarter Sanofi - American Depositary Shares reported $13 billion in Revenue and $.89 earnings per share. This fell short of revenue expectation by $-251 million and exceeded earnings estimates by $.05.

In the last 3 years, SNY traded as high as $60.12 and as low as $42.63.

The top ETF exchange traded funds that SNY belongs to (by Net Assets): PVAL, PPH, FVD, AVDE, FENI.

SNY has underperformed the market in the last year with a price return of -21.3% while the SPY ETF gained +18.7%. SNY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.1% and -4.7%, respectively, while the SPY returned -1.7% and -2.5%, respectively.

SNY support price is $44.28 and resistance is $45.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNY shares will trade within this expected range on the day.